Page 299 - Williams Hematology ( PDFDrive )
P. 299

274            Part IV:  Molecular and Cellular Hematology                                                                                            Chapter 18:  Hematopoietic Stem Cells, Progenitors, and Cytokines            275




                 123. Molnar A, Georgopoulos K: The Ikaros gene encodes a family of functionally diverse     154. Rafii S, Shapiro F, Pettengell R, et al: Human bone marrow microvascular endothelial
                  zinc finger DNA-binding proteins. Mol Cell Biol 14:8292, 1994.  cells support long-term proliferation and differentiation of myeloid and megakaryo-
                 124. Wang JH, Nichogiannopoulou A, Wu L, et al: Selective defects in the development of   cytic progenitors. Blood 86:3353, 1995.
                  the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity     155. Sugiyama T, Kohara H, Noda M, Nagasawa T: Maintenance of the hematopoietic stem
                  5:537, 1996.                                           cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches.
                 125. McKercher SR, Torbett BE, Anderson KL, et al: Targeted disruption of the PU.1 gene   Immunity 25:977, 2006.
                  results in multiple hematopoietic abnormalities. EMBO J 15:5647, 1996.    156. Calvi LM, Link DC: Cellular complexity of the bone marrow hematopoietic stem cell
                 126. Begley CG, Aplan PD, Denning SM, et al: The gene SCL is expressed during early   niche. Calcif Tissue Int 94:112, 2014.
                  hematopoiesis and encodes a differentiation-related DNA-binding motif.  Proc Natl     157. Islam A, Glomski C, Henderson ES: Bone lining (endosteal) cells and hematopoiesis:
                  Acad Sci U S A 86:10128, 1989.                         A light microscopic study of normal and pathologic human bone marrow in plas-
                 127. Lecuyer E, Hoang T: SCL: From the origin of hematopoiesis to stem cells and leukemia.   tic-embedded sections. Anat Rec 227:300, 1990.
                  Exp Hematol 32:11, 2004.                              158. Ellis SL, Nilsson SK: The location and cellular composition of the hemopoietic stem cell
                 128. Shivdasani RA, Mayer EL, Orkin SH: Absence of blood formation in mice lacking the   niche. Cytotherapy 14:135, 2012.
                  T-cell leukaemia oncoprotein tal-1/SCL. Nature 373:432, 1995.    159. Keating A: Mesenchymal stromal cells. Curr Opin Hematol 13:419, 2006.
                 129. Brady G, Billia F, Knox J, et al: Analysis of gene expression in a complex differentiation     160. Dazzi F, Horwood NJ: Potential of mesenchymal stem cell therapy. Curr Opin Oncol
                  hierarchy by global amplification of cDNA from single cells. Curr Biol 5:909, 1995.  19:650, 2007.
                 130. Hoang T, Paradis E, Brady G, et al: Opposing effects of the basic helix-loop-helix tran-    161. Lok S, Kaushansky K, Holly RD, et al: Cloning and expression of murine thrombopoie-
                  scription factor SCL on erythroid and monocytic differentiation. Blood 87:102, 1996.  tin cDNA and stimulation of platelet production in vivo. Nature 369:565, 1994.
                 131. Caceres-Cortes JR, Krosl G, Tessier N, et al: Steel factor sustains SCL expression and the     162. McCarty JM, Sprugel KH, Fox NE, et al: Murine thrombopoietin mRNA levels are
                  survival of purified CD34+ bone marrow cells in the absence of detectable cell differen-  modulated by platelet count. Blood 86:3668, 1995.
                  tiation. Stem Cells 19:59, 2001.                      163. Sungaran R, Markovic B, Chong BH: Localization and regulation of thrombopoietin
                 132. Martin DI, Tsai SF, Orkin SH: Increased gamma-globin expression in a nondeletion   mRNa expression in human kidney, liver, bone marrow, and spleen using in situ hybrid-
                  HPFH mediated by an erythroid-specific DNA-binding factor. Nature 338:435, 1989.  ization. Blood 89:101, 1997.
                 133. Persons DA, Allay JA, Allay ER, et al: Enforced expression of the GATA-2 transcription     164. Solanilla A, Dechanet J, El Andaloussi A, et al: CD40-ligand stimulates myelopoiesis by
                  factor blocks normal hematopoiesis. Blood 93:488, 1999.  regulating flt3-ligand and thrombopoietin production in bone marrow stromal cells.
                 134. Deveaux S, Filipe A, Lemarchandel V, et al: Analysis of the thrombopoietin receptor   Blood 95:3758, 2000.
                  (MPL) promoter implicates GATA and Ets proteins in the coregulation of megakaryo-    165. Quirici N, Soligo D, Caneva L, et al: Differentiation and expansion of endothelial cells
                  cyte-specific genes. Blood 87:4678, 1996.              from human bone marrow CD133(+) cells. Br J Haematol 115:186, 2001.
                 136. Yamaguchi Y, Ackerman SJ, Minegishi N, et al: Mechanisms of transcription in eosino-    166. Yanai N, Sekine C, Yagita H, et al: Roles for integrin very late activation antigen-4 in
                  phils: GATA-1, but not GATA-2, transactivates the promoter of the eosinophil granule   stroma-dependent erythropoiesis. Blood 83:2844, 1994.
                  major basic protein gene. Blood 91:3447, 1998.        167. Jung Y, Wang J, Song J, et al: Annexin II expressed by osteoblasts and endothelial cells
                 136. Dykstra B, Olthof S, Schreuder J, et al: Clonal analysis reveals multiple functional   regulates stem cell adhesion, homing, and engraftment following transplantation. Blood
                  defects of aged murine hematopoietic stem cells. J Exp Med 208:2691, 2011.  110:82, 2007.
                 137. Pang WW, Price EA, Sahoo D, et al: Human bone marrow hematopoietic stem cells     168. Scott LM PG, Koni P, Papayannopoulou T: Adult mice with conditional VCAM-1 abla-
                  are increased in frequency and myeloid-biased with age.  Proc Natl Acad Sci U S A   tion show altered hemopoietic progenitor biodistribution, homing and regeneration
                  108:20012, 2011.                                       patterns. Blood 102, 2003.
                 138. Geiger H, de Haan G, Florian MC: The aging hematopoietic stem cell compartment.     169. Carstanjen D, Ulbricht N, Iacone A, et al: Matrix metalloproteinase-9 (gelatinase B) is
                  Nat Rev Immunol 13:376, 2013.                          elevated during mobilization of peripheral blood progenitor cells by G-CSF. Transfu-
                 139. Kaushansky K, Lin N, Adamson JW: Interleukin 1 stimulates fibroblasts to synthesize   sion 42:588, 2002.
                  granulocyte-macrophage and granulocyte colony-stimulating factors. Mechanism for     170. Yamazaki K, Allen TD: Ultrastructural morphometric study of efferent nerve terminals
                  the hematopoietic response to inflammation. J Clin Invest 81:92, 1988.  on murine bone marrow stromal cells, and the recognition of a novel anatomical unit:
                 140. Toksoz  D,  Zsebo  KM,  Smith  KA,  et  al:  Support  of human  hematopoiesis  in  long-  the “neuro-reticular complex” Am J AnatJ Anat 187:261, 1990.
                  term bone marrow cultures by murine stromal cells selectively expressing the mem-    171. Méndez-Ferrer S, Michurina TV, Ferraro F, et al: Mesenchymal and hematopoietic stem
                  brane-bound and secreted forms of the human homolog of the steel gene product, stem   cells form a unique bone marrow niche. Nature 466:829, 2010.
                  cell factor. Proc Natl Acad Sci U S A 89:7350, 1992.    172. Lucas D, Scheiermann C, Chow A, et al: Chemotherapy-induced bone marrow nerve
                 141. Selleri C, Maciejewski JP, Sato T, et al: Interferon-gamma constitutively expressed in the   injury impairs hematopoietic regeneration. Nat Med 19:695, 2013.
                  stromal microenvironment of human marrow cultures mediates potent hematopoietic     173. Yuzawa S, Opatowsky Y, Zhang Z, et al: Structural basis for activation of the receptor
                  inhibition. Blood 87:4149, 1996.                       tyrosine kinase kit by stem cell factor. Cell 130:323, 2007.
                 142. Guerriero A, Worford L, Holland HK, et al: Thrombopoietin is synthesized by bone     174. Liang J, Wu YL, Chen BJ, et al: The c-kit receptor-mediated signal transduction and
                  marrow stromal cells. Blood 90:3444, 1997.             tumor-related diseases. Int J Biol Sci 9:435, 2013.
                 143. Miyazawa K, Williams DA, Gotoh A, et al: Membrane-bound Steel factor induces more     175. Li CL, Johnson GR: Stem-cell factor enhances the survival but not the self-renewal of
                  persistent tyrosine kinase activation and longer life span of c-kit gene-encoded protein   murine hematopoietic long-term repopulating cells. Blood 84:408, 1994.
                  than its soluble form. Blood 85:641, 1995.            176. Bernstein ID, Andrews RG, Zsebo KM: Recombinant human stem-cell factor enhances
                 144. Gordon MY, Riley GP, Watt SM, et al: Compartmentalization of a haematopoietic   the formation of colonies by CD34+ and CD34+Lin cells, and the generation of colony-
                  growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenviron-  forming cell progeny from CD34+Lin cells cultured with interleukin-3, granulocyte
                  ment. Nature 326:403, 1987.                            colony-stimulating factor, or granulocyte-macrophage colony-stimulating factor. Blood
                 145. Artavanis-Tsakonas S, Matsuno K, Fortini ME: Notch signaling.  Science 268:225,     77:2316, 1991.
                  1995.                                                 177. Brandt J, Briddell RA, Srour EF, et al: Role of c-Kit ligand in the expansion of human
                 146. Nye JS, Kopan R: Developmental signaling. Vertebrate ligands for Notch. Curr Biol   hematopoietic progenitor cells. Blood 79:634, 1992.
                  5:966, 1995.                                          178. Ariyama Y, Misawa S, Sonoda Y: Synergistic effects of stem-cell factor and interleukin-6
                 147. Karanu FN, Murdoch B, Miyabayashi T, et al: Human homologues of Delta-1 and   or interleukin-11 on the expansion of murine hematopoietic progenitors in liquid sus-
                  Delta-4 function as mitogenic regulators of primitive human hematopoietic cells. Blood   pension-culture. Stem Cells 13:404, 1995.
                  97:1960, 2001.                                        179. Kent D, Copley M, Benz C, et al: Regulation of hematopoietic stem cells by the steel
                 148. Kapur R, Cooper R, Zhang L, et al: Cross-talk between alpha(4)beta(1)/alpha(5)beta(1)   factor/KIT signaling pathway. Clin Cancer Res 14:1926, 2008.
                  and c-Kit results in opposing effect on growth and survival of hematopoietic cells via     180. Wu H, Klingmuller U, Acurio A, et al: Functional interaction of erythropoietin and
                  the activation of focal adhesion kinase, mitogen-activated protein kinase, and Akt sig-  stem cell factor receptors is essential for erythroid colony formation. Proc Natl Acad Sci
                  naling pathways. Blood 97:1975, 2001.                  U S A 94:1806, 1997.
                 149. Shaklai M, Tavassoli M: Cellular relationship in the rat bone marrow studied by freeze     181. Lyman SD, James L, Johnson L, et al: Cloning of the human homolog of the murine
                  fracture and lanthanum impregnation thin-sectioning electron microscopy. J Ultrastruct   Flt3 ligand—A growth factor for early hematopoietic progenitor cells. Blood 83:2795,
                  Res 69:343, 1979.                                      1994.
                 150. Westen H, Bainton DF: Association of alkaline-phosphatase-positive reticulum cells in     182. Rosnet O, Schiff C, Pebusque MJ, et al: Human Flt3/Flk2 gene—CDNA cloning and
                  bone marrow with granulocytic precursors. J Exp Med 150:919, 1979.  expression in hematopoietic cells. Blood 82:1110, 1993.
                 151. Tavassoli M, Aoki M: Localization of megakaryocytes in the bone marrow. Blood Cells     183. Parcells BW, Ikeda AK, Simms-Waldrip T, et al: FMS-like tyrosine kinase 3 in normal
                  15:3, 1989.                                            hematopoiesis and acute myeloid leukemia. Stem Cells 24:1174, 2006.
                 152. Blazsek I, Chagraoui J, Peault B: Ontogenic emergence of the hematon, a morphoge-    184. Thiede C, Steudel C, Mohr B, et al: Analysis of FLT3-activating mutations in 979
                  netic stromal unit that supports multipotential hematopoietic progenitors in mouse   patients with acute myelogenous leukemia: Association with FAB subtypes and identi-
                  bone marrow. Blood 96:3763, 2000.                      fication of subgroups with poor prognosis. Blood 99:4326, 2002.
                 153. Simmons PJ, Masinovsky B, Longenecker BM, et al: Vascular cell adhesion molecule-1     185. Zwaan CM, Meshinchi S, Radich JP, et al: FLT3 internal tandem duplication in 234
                  expressed by bone marrow stromal cells mediates the binding of hematopoietic progen-  children with acute myeloid leukemia: Prognostic significance and relation to cellular
                  itor cells. Blood 80:388, 1992.                        drug resistance. Blood 102:2387, 2003.







          Kaushansky_chapter 18_p0257-0278.indd   274                                                                   9/19/15   12:06 AM
   294   295   296   297   298   299   300   301   302   303   304